company background image
BIOX logo

Bioceres Crop Solutions NasdaqGS:BIOX Stok Raporu

Son Fiyat

US$6.46

Piyasa Değeri

US$399.7m

7D

-5.6%

1Y

-46.1%

Güncellenmiş

20 Nov, 2024

Veri

Şirket Finansalları +

Bioceres Crop Solutions Corp.

NasdaqGS:BIOX Stok Raporu

Piyasa değeri: US$399.7m

Bioceres Crop Solutions Corp. Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Bioceres Crop Solutions
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$6.46
52 Haftanın En Yüksek SeviyesiUS$14.05
52 Haftanın En Düşük SeviyesiUS$5.71
Beta0.47
11 Aylık Değişim-12.94%
3 Aylık Değişim-34.88%
1 Yıllık Değişim-46.08%
33 Yıllık Değişim-56.82%
5 Yıllık Değişim11.38%
Halka arzdan bu yana değişim31.84%

Son Haberler & Güncellemeler

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Recent updates

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Hissedar Getirileri

BIOXUS ChemicalsUS Pazar
7D-5.6%-1.1%-1.0%
1Y-46.1%9.8%30.3%

Getiri vs. Endüstri: BIOX geçen yıl % 9.8 oranında getiri sağlayan US Chemicals sektörünün gerisinde kaldı.

Getiri vs Piyasa: BIOX geçen yıl % 30.3 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is BIOX's price volatile compared to industry and market?
BIOX volatility
BIOX Average Weekly Movement6.4%
Chemicals Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

İstikrarlı Hisse Senedi Fiyatı: BIOX son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: BIOX 'nin haftalık oynaklığı ( 6% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
2001n/aFederico Truccoinvestors.biocerescrops.com/home/default.aspx

Bioceres Crop Solutions Corp. iştirakleri ile birlikte mahsul verimliliği çözümleri sunmaktadır. Tohum ve Entegre Ürünler, Bitki Koruma ve Bitki Besleme segmentleri aracılığıyla faaliyet göstermektedir. Tohum ve Entegre Ürünler segmenti, daha sağlıklı ve daha yüksek verimli mahsuller için tohum özellikleri, germplazmlar ve tohum işleme paketleri sağlar.

Bioceres Crop Solutions Corp. Temel Bilgiler Özeti

Bioceres Crop Solutions'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
BIOX temel i̇stati̇sti̇kler
Piyasa değeriUS$399.72m
Kazançlar(TTM)US$2.44m
Gelir(TTM)US$441.23m

166.2x

F/K Oranı

0.9x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
BIOX gelir tablosu (TTM)
GelirUS$441.23m
Gelir MaliyetiUS$265.14m
Brüt KârUS$176.09m
Diğer GiderlerUS$173.65m
KazançlarUS$2.44m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)0.039
Brüt Marj39.91%
Net Kâr Marjı0.55%
Borç/Özkaynak Oranı72.3%

BIOX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün